On Friday, JMP Securities revised its price target for Evolent Health (NYSE:EVH) shares, reducing it from $18.00 to $12.00, while maintaining a Market Outperform rating for the company.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

JMP Securities’ price target indicates a potential upside of 25.99% from the stock’s previous close. A number of other analysts also recently issued reports on MDGL.

JMP Securities analyst Mikhail Goberman initiated coverage of Mr. Cooper (COOP) with an Outperform rating and $115 price target suggesting potential price upside of 25%. The firm believes the ...

LGI Homes (NASDAQ:LGIH – Get Free Report)‘s stock had its “market outperform” rating reiterated by equities research analysts at JMP Securities in a report released on Friday,Benzinga reports.

Fintel reports that on January 2, 2025, JMP Securities downgraded their outlook for Uber Technologies (WBAG:UBER) from Market Outperform to Market Perform. There are 2,993 funds or institutions ...

Fintel reports that on January 21, 2025, JMP Securities initiated coverage of Roku (NasdaqGS:ROKU) with a Market Outperform recommendation. As of December 23, 2024, the average one-year price ...

JMP Securities raised the price targets on Cloudflare (NYSE:NET) and CyberArk Software (NASDAQ:CYBR), while highlighting an industry overview of cybersecurity stocks ahead of quarterly results.

JMP Securities analyst Matthew Carletti raised the firm’s price target on Goosehead Insurance (GSHD) to $125 from $115 and keeps an Outperform rating on the shares. JMP expects Q4 Insurance ...

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where Cloudflare, Inc. (NYSE:NET) stands against the other AI stocks.

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.